Tulio de Oliveira

@tuliodna.bsky.social

Professor of medical research leading global genomics surveillance. Director CERI at Stellenbosch University and KRISP at UKZN, South Africa. Views my own.

I am very honored to have been selected as a the second-ever African based fellow of the ISCB, International Society for Computational Biology. Being a fellow is highest honor awarded by ISCB and is recognized as the career distinction in the global bioinformatics & computational biology community.

Bild

In the age of scientific misinformation & disinformation, we decided to invest in to create a scientific magazine that is curated using professional journalists and media communicators to highlight excellence of African science and innovation! Access the full magazine online at: ceri.africa/the-gem/

Bild

As we embrace Friday, let's remember the importance of letting our hair down—relaxing, being ourselves, and acting freely without the constraints of rules or the opinions of others. I just returned from a wonderful trip to the wildflowers, waterfalls, and mountains. Wishing everyone a happy Friday!

Bild

This Saturday is Nelson Mandela Day, so honored to be given a special lecture on Science, Human Rights and the Power of Inclusion. Scientific excellence thrives when inclusion, equality, and respect are treated not only as values but as guiding principles. Join online - tinyurl.com/4xxjzjv5

Bild

Friday late afternoon is for large genomics runs at one of the largest and most altomated genomics lab in Africa and the world! South African science to lead and protect the world at CERI - Centre for Epidemic Response and Innovation Stellenbosch University

Bild

I am pleased to introduce Abduljalal Nadabo, from Nigeria, a new African STARS Fellow, who is a pharmacist, researcher, and health policy fellow. He works at the intersection of vaccinology, regulatory science, and vaccine delivery innovation, focusing on Sub-Saharan Africa.

Bild

Tomorrow, I will be at the headquarters of the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden, to give a presentation on how to accelerate genomics surveillance and innovation in Africa. To join the meeting, please follow this link: lnkd.in/dhGxwDNN

Bild

Lenacapavir is the most exciting tool to fight AIDS since antiretroviral therapy by Peter Sands, head of Global Fund. Lenacapavir is being rolled out in 24 African countries and Gilead Sciences has already approved to be generic! So the most potent tool will be easily and cheaply available.

Bild

Though provoking presentation by Prof Moffat Nyirenda on how diabetes presents like a very different disease in Africans! No need for obesity to develop diabetes in Uganda! Are we talking about two different diseases? MRC/UVRI & LSHTM Uganda Research Unit Novo Nordisk Foundation Science Summit

Bild

What an amazing and inspiring lecture by Matthias H. Tschöp on the multiple benefits of GLP-1 and other anti obesity drugs! From cancer to alcohol addiction at Novo Nordisk Foundation Science Summit in Denmark LMU Munich – Ludwig-Maximilians-Universität München

Bild

Today in Helsinki, I had the opportunity to meet with titans and founders, including Peter Vesterbacka, the founder of Slush and a notable figure in innovation. This meeting fostered great collaboration as we prepare for Slush, while focusing on bringing top Finnish entrepreneurs to SWEAT Africa.

Bild

This program instills hope in the world. Its main message is clear: "We can work together, without borders, to advance new therapies & diagnostics to the clinic." This collaborative effort can be approached positively & gently providing inspiration and capacity for numerous countries & universities.

Bild

What to say? So inspiring to be in one of the most advanced Medical Innovation program in the world, the SPARK Global, having its annual meeting in Helsinki, Finland! Over 1000 spin outs created in 30 countries

Bild

Long days in Finland! it is 10pm and sun still shinning as I arrive to the annual innovation meeting. A Special one as SPARK Stanford 20 years celebration and Finland 10 years of biotech and healthtech innovation.

Bild

This week brought even more exciting news! A once-weekly Lenacapavir-based pill has now demonstrated similar outcomes to daily aARVs, i.e. non-inferiority. This could significantly impact treatment adherence and quality of life of people living with HIV www.clinicaltrialsarena.com/news/gilead-....

Gilead and MSD’s once-weekly HIV pill meets primary endpoints in Phase III trials

Gilead and MSD will be filing the data from the Phase III trials of the once-weekly HIV pill to regulatory authorities.

clinicaltrialsarena.com

This week, nearly 100 international science communicators gathered at CERI to address the pressing issue of protecting scientists from aggression. Many scientists have expressed concerns about sharing scientific results due to the rise of anti-science sentiment from certain far-right factions

BildBildBildBild